Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

Overview

About this study

The purpose of this study is to show a reduction in the proportion of benign lung nodules experiencing invasive procedures (biopsies or surgery) between a group of patients managed by standard of care with Nodify XL2 results and a group managed by standard of care blinded from Nodify XL2 results.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

David Midthun, M.D.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Jodi Mahon

(507) 293-0694

Mahon.Jodi@mayo.edu

More information

Publications

Publications are currently not available